BD 231213 - Sensi-Disc Clindamycin CC-2 (Perishable Product; Must be Refrigerated; Non-Returnable) (Continental US Only)

BD 231213 - Sensi-Disc Clindamycin CC-2 (Perishable Product; Must be Refrigerated; Non-Returnable) (Continental US Only)

The BD 231213 Disk Susceptibility Sensi-Disc Clindamycin 2mcg is a high-quality antimicrobial susceptibility testing (AST) reagent designed for determining bacterial sensitivity to clindamycin, a lincosamide antibiotic commonly used for treating infections caused by Gram-positive cocci and anaerobes. Each sterile paper disk contains 2 micrograms of clindamycin, ensuring a standardized and reliable diffusion gradient for interpreting susceptibility results using the Kirby-Bauer disk diffusion method. Manufactured under BDs strict quality standards, this Sensi-Disc supports accurate and reproducible results in diagnostic microbiology laboratories.

Key Benefits

The BD 231213 Clindamycin 2mcg Sensi-Disc offers consistent potency, uniform diffusion, and highly reproducible inhibition zone formation. Its reliable antibiotic delivery helps laboratories identify clindamycin susceptibility and detect resistance mechanisms such as inducible clindamycin resistance (MLS_Bphenotype) when used alongside erythromycin disks for D-testing. The sterile, single-use format minimizes contamination risk and enhances workflow efficiency. BDs advanced manufacturing process ensures dependable performance across high-volume AST testing environments.

Compatibility and Applications

This Sensi-Disc is compatible with standard Mueller-Hinton agar and follows CLSI and EUCAST guidelines for disk diffusion AST. It is commonly used for testing:

• Staphylococcus aureusand other staphylococci
• Streptococcusspecies (with appropriate media adjustments)
• Anaerobic bacteria in supplemental workflows
• Organisms involved in skin, soft tissue, respiratory, and bone infections

Clindamycin testing is particularly important in detecting inducible resistance, monitoring therapy options, and guiding treatment decisions for Gram-positive infections.

Usage Guidelines

Prepare a bacterial suspension adjusted to a 0.5 McFarland standard and uniformly inoculate a Mueller-Hinton agar plate. Use sterile forceps or a disk dispenser to place the BD 231213 Clindamycin 2mcg disk onto the agar surface. Incubate plates at 3537C for 1620 hours following CLSI or EUCAST recommendations. Measure the inhibition zone diameter using a calibrated ruler or automated zone reader and interpret results according to current breakpoints. For detecting inducible resistance, position an erythromycin disk nearby (D-test) and evaluate zone flattening patterns. Store disks at 28C in sealed containers with desiccants.

Certifications, Safety Standards, and Regulatory Approvals

The BD 231213 Sensi-Disc is manufactured under ISO 9001 and ISO 13485 certified facilities and complies with FDA and CE standards for in vitro diagnostic (IVD) devices. Each batch is tested for antibiotic potency, uniformity, stability, and sterility. BDs adherence to CLSI performance criteria ensures reliable, reproducible susceptibility testing results.

Comparison with Competitor Products

BD Sensi-Discs consistently outperform generic susceptibility disks in diffusion uniformity, potency stability, and lot-to-lot consistency. Many competitor disks show variability in antibiotic loading or inconsistent zone formation, which can lead to incorrect interpretationespecially critical in clindamycin testing where D-zone detection depends on precise antibiotic diffusion. BDs high manufacturing precision ensures dependable, clinically actionable AST results.

Typical User Profile and Application Scenarios

This clindamycin Sensi-Disc is used by clinical microbiologists, laboratory technologists, infectious disease experts, and research scientists. It is ideal for:

• Routine clinical AST panels
• MRSA and MSSA susceptibility testing
• Evaluation of Gram-positive respiratory or soft tissue infections
• D-test workflows to detect inducible clindamycin resistance
• Resistance surveillance and epidemiological studies

Best Practices for Use and Maintenance

Handle disks using sterile forceps and avoid touching the antibiotic surface. Allow refrigerated disks to reach room temperature before opening to prevent condensation. Verify performance using quality control organisms such asStaphylococcus aureusATCC 25923. Store disks properly to maintain potency, and never use expired or compromised disks. Dispose of used materials as biohazard waste following institutional protocols.

Regulatory and Safety Information

The BD 231213 Sensi-Disc Clindamycin 2mcg is intended for in vitro diagnostic use by trained microbiology personnel. Follow biosafety level 2 precautions while working with pathogenic bacterial isolates. Use appropriate PPE including gloves, protective eyewear, and laboratory coats. Dispose of all testing materials according to regulatory and institutional waste management requirements.

How to Order

To order the BD 231213 Disk Susceptibility Sensi-Disc Clindamycin 2mcg, add the item to your cart and complete the purchase through CIA Medicals secure online checkout. For bulk quantities, laboratory contracts, or technical support, contact CIA Medical customer service at (312) 275-5850 or submit an inquiry using the contact form on this page. Our team is available to provide pricing, availability, and product documentation tailored to your AST workflow needs.